EXPERIENCES WITH LYMPHOCYTE IMMUNOTHERAPY IN EXPERIMENTAL TUMOR SYSTEMS

被引：0
|
作者：
FISHER, B
SAFFER, EA
FISHER, ER
机构：
来源：
CANCER | 1971年 / 27卷 / 04期
关键词：
D O I：
10.1002/1097-0142(197104)27:4<771::AID-CNCR2820270404>3.0.CO;2-T
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：771 / &
相关论文
共 50 条
  • [41] MR IMAGING IN AN EXPERIMENTAL-MODEL OF BRAIN-TUMOR IMMUNOTHERAPY
    BLANKENBERG, F
    CONLEY, FK
    SAYRE, J
    ENZMANN, D
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1991, 12 (03) : 543 - 548
  • [42] Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy
    Tian, Weihong
    Wei, Wangzhi
    Qin, Gaofeng
    Bao, Xuanwen
    Tong, Xuecheng
    Zhou, Min
    Xue, Yuan
    Zhang, Yu
    Shao, Qixiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Brain tumor inhibition in experimental model by restorative immunotherapy with a corpuscular antigen
    Gangopaddhyay, Soven Kumar
    Sarkar, Susobhan
    Begum, Zarina
    Chaudhuri, Swapna
    Chaudhuri, Samaresh
    Indian Journal of Experimental Biology, 2003, 41 (08) : 805 - 813
  • [44] EXPERIMENTAL CANCER IMMUNOTHERAPY - MODIFICATION OF TUMOR-CELLS TO INCREASE IMMUNOGENICITY
    RIOS, A
    SIMMONS, RL
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 276 (SEP3) : 45 - 60
  • [45] The immunotherapy of tumor
    Wan, Q
    Zhang, CL
    Zhai, CY
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1999, 26 (02) : 99 - 101
  • [46] Systemic autologous lymphocyte transfer can enhance tumor-infiltrating lymphocyte infiltration in glioblastoma and license co-stimulatory immunotherapy
    Singh, Kirit
    Hotchkiss, Kelly M.
    Moelker, Eliese
    Archer, Gary E.
    Sampson, John H.
    Khasraw, Mustafa
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Some experiences with experimental high level fusion systems
    Biermann, J.
    2007 PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION, VOLS 1-4, 2007, : 1819 - 1822
  • [48] LYMPHOCYTE PRODUCED SUBSTANCES IN IMMUNOPHARMACOLOGY AND IMMUNOTHERAPY
    DUMONDE, DC
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1984, 4 (02): : 77 - 84
  • [49] Which are the risks of intradermal lymphocyte immunotherapy?
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 503 - 504
  • [50] Cytotoxic lymphocyte-mediated immunotherapy
    Smyth, MJ
    Kershaw, MH
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (06): : 852 - 858
12345